EUROBIO-SCIENTIFIC (ALERS.PA) Stock Analyst Earnings Estimates
EPA:ALERS - Euronext Paris - Matif - FR0013240934 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 184.712M -2.19% | 152.607M -17.38% | 130.003M -14.81% | 142.14M 9.34% | 152.54M 7.32% | 160.89M 5.47% | |
| EBITDA YoY % growth | 77.058M -12.91% | 40.094M -47.97% | 28.788M -28.20% | 28.016M -2.68% | 31.724M 13.24% | 36.153M 13.96% | |
| EBIT YoY % growth | 70.117M -13.66% | 30.869M -55.98% | 14.539M -52.90% | 23.999M 65.07% | 27.81M 15.88% | 32.136M 15.56% | |
| Operating Margin | 37.96% | 20.23% | 11.18% | 16.88% | 18.23% | 19.97% | |
| EPS YoY % growth | N/A -7.70% | N/A -60.93% | N/A -60.35% | 0.91 -2.22% | 1.14 26.14% | 1.46 27.93% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 73.274M 23.86% | % | ||
| Q4 2023 Q2Q % growth | 70.845M 2.89% | % | ||
| Q2 2023 Q2Q % growth | 59.158M -29.37% | % | ||
| Q4 2022 Q2Q % growth | 68.852M -22.62% | % | ||
| Q2 2022 Q2Q % growth | 83.755M -12.51% | % | ||
| Q4 2021 Q2Q % growth | 88.981M -29.72% | % | ||
| Q2 2021 Q2Q % growth | 95.731M 53.79% | % | ||
| Q4 2020 Q2Q % growth | 126.607M 327.96% | % | ||
| Q2 2020 Q2Q % growth | 62.249M 111.11% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |